| Tolerating subretinal fluid in neovascular age-related macular degeneration treated with ranibizumab using a treat-and-extend regimen: FLUID study 24-month results RH Guymer, CM Markey, IL McAllister, MC Gillies, AP Hunyor, JJ Arnold, ... Ophthalmology 126 (5), 723-734, 2019 | 288 | 2019 |
| Intravitreal aflibercept for treatment-resistant neovascular age-related macular degeneration AA Chang, H Li, GK Broadhead, T Hong, TE Schlub, W Wijeyakumar, ... Ophthalmology 121 (1), 188-192, 2014 | 173 | 2014 |
| Visual impairment, hearing loss and cognitive function in an older population: longitudinal findings from the Blue Mountains Eye Study T Hong, P Mitchell, G Burlutsky, G Liew, JJ Wang PloS one 11 (1), e0147646, 2016 | 148 | 2016 |
| Visual impairment and the incidence of falls and fractures among older people: longitudinal findings from the Blue Mountains Eye Study T Hong, P Mitchell, G Burlutsky, C Samarawickrama, JJ Wang Investigative ophthalmology & visual science 55 (11), 7589-7593, 2014 | 131 | 2014 |
| Development and progression of diabetic retinopathy 12 months after phacoemulsification cataract surgery T Hong, P Mitchell, T de Loryn, E Rochtchina, S Cugati, JJ Wang Ophthalmology 116 (8), 1510-1514, 2009 | 105 | 2009 |
| The burden of neovascular age-related macular degeneration: a patient’s perspective KL Spooner, CT Mhlanga, TH Hong, GK Broadhead, AA Chang Clinical Ophthalmology, 2483-2491, 2018 | 101 | 2018 |
| Correction of visual impairment by cataract surgery and improved survival in older persons: the Blue Mountains Eye Study cohort CS Fong, P Mitchell, E Rochtchina, ET Teber, T Hong, JJ Wang Ophthalmology 120 (9), 1720-1727, 2013 | 96 | 2013 |
| A review and meta-analysis of the association between C-reactive protein and age-related macular degeneration T Hong, AG Tan, P Mitchell, JJ Wang Survey of ophthalmology 56 (3), 184-194, 2011 | 84 | 2011 |
| Anti-VEGF therapy for diabetic eye diseases B Bahrami, T Hong, MC Gilles, A Chang Asia-Pacific journal of ophthalmology 6 (6), 535-545, 2017 | 81 | 2017 |
| Incidence and progression of geographic atrophy: observations from a population-based cohort N Joachim, P Mitchell, A Kifley, E Rochtchina, T Hong, JJ Wang Ophthalmology 120 (10), 2042-2050, 2013 | 80 | 2013 |
| Saffron therapy for the treatment of mild/moderate age-related macular degeneration: a randomised clinical trial GK Broadhead, JR Grigg, P McCluskey, T Hong, TE Schlub, AA Chang Graefe's Archive for Clinical and Experimental Ophthalmology 257, 31-40, 2019 | 78 | 2019 |
| Switching to aflibercept among patients with treatment-resistant neovascular age-related macular degeneration: a systematic review with meta-analysis K Spooner, T Hong, W Wijeyakumar, AA Chang Clinical Ophthalmology, 161-177, 2017 | 71 | 2017 |
| Diabetic macular oedema: pathophysiology, management challenges and treatment resistance B Bahrami, M Zhu, T Hong, A Chang Diabetologia 59 (8), 1594-1608, 2016 | 67 | 2016 |
| Treating the untreatable patient: current options for the management of treatment‐resistant neovascular age‐related macular degeneration GK Broadhead, T Hong, AA Chang Acta ophthalmologica 92 (8), 713-723, 2014 | 59 | 2014 |
| Three-year incidence and factors associated with posterior capsule opacification after cataract surgery: The Australian Prospective Cataract Surgery and Age-related Macular … CSU Fong, P Mitchell, E Rochtchina, S Cugati, T Hong, JJ Wang American journal of ophthalmology 157 (1), 171-179. e1, 2014 | 57 | 2014 |
| Response of pigment epithelial detachments to intravitreal aflibercept among patients with treatment-resistant neovascular age-related macular degeneration GK Broadhead, T Hong, M Zhu, H Li, TE Schlub, W Wijeyakumar, ... Retina 35 (5), 975-981, 2015 | 54 | 2015 |
| Visual impairment and depressive symptoms in an older Australian cohort: longitudinal findings from the Blue Mountains Eye Study T Hong, P Mitchell, G Burlutsky, B Gopinath, G Liew, JJ Wang British Journal of Ophthalmology 99 (8), 1017-1021, 2015 | 52 | 2015 |
| Switching therapy from bevacizumab to aflibercept for the management of persistent diabetic macular edema B Bahrami, T Hong, M Zhu, TE Schlub, A Chang Graefe's Archive for Clinical and Experimental Ophthalmology 255, 1133-1140, 2017 | 51 | 2017 |
| Five-year outcomes of retinal vein occlusion treated with vascular endothelial growth factor inhibitors K Spooner, S Fraser-Bell, T Hong, AA Chang BMJ Open Ophthalmology 4 (1), e000249, 2019 | 49 | 2019 |
| Intravitreal ranibizumab for neovascular age-related macular degeneration in clinical practice: five-year treatment outcomes M Zhu, JK Chew, GK Broadhead, K Luo, N Joachim, T Hong, A Syed, ... Graefe's Archive for Clinical and Experimental Ophthalmology 253, 1217-1225, 2015 | 48 | 2015 |
